Merck & Co., Inc. is a research-intensive biopharmaceutical company engaged in research to deliver health solutions that advance the prevention and treatment of diseases in people and animals. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. It is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 17.89です。
高配当
同社は高配当銘柄であり、最新の配当性向は46.40%です。
安定配当
同社は過去5年間にわたり継続的に配当を実施しており、最新の配当性向は46.40%です。
割安
同社の最新のPEは12.94で、過去3年間の水準と比較して安値圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は2.02B株で、前四半期比で0.81%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を251.75M株保有しています。
市場活動が低調
同社への投資家の関心は低下しており、20日間の売買回転率は-0.02です。